Transradial versus Transfemoral Access and the Risk of Acute Kidney Injury following Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Propensity-Score-Matched Studies.
Journal
Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
11
2021
accepted:
25
01
2022
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
The aim of this study is to examine the association between vascular access sites and the incidence of AKI in patients with STEMI undergoing primary PCI. Emerging evidence has suggested that transradial access (TRA) may be associated with lower rates of acute kidney injury (AKI) as compared with transfemoral access (TFA). However, most of these studies have included a nonselected study population undergoing diagnostic cardiac catheterization or percutaneous coronary intervention (PCI). Data on the association between TRA and AKI in this setting of STEMI are limited and with conflicting results. We systematically searched PubMed, Embase, and Scopus for abstracts and full-text articles from inception to July 13 A total of 10,093 studies were found. After applying our inclusion criteria, 5 studies from 2014 to 2021 with a total of 8,536 STEMI patients were included. TRA was not significantly associated with a reduced risk for AKI compared with TFA (odds ratio 0.85, 95% CI 0.71-1.01, Transradial access was not significantly associated with lower risk of AKI in patients undergoing primary PCI for STEMI compared with TFA. Larger studies are needed to clarify this outcome.
Sections du résumé
Objectives
UNASSIGNED
The aim of this study is to examine the association between vascular access sites and the incidence of AKI in patients with STEMI undergoing primary PCI.
Background
UNASSIGNED
Emerging evidence has suggested that transradial access (TRA) may be associated with lower rates of acute kidney injury (AKI) as compared with transfemoral access (TFA). However, most of these studies have included a nonselected study population undergoing diagnostic cardiac catheterization or percutaneous coronary intervention (PCI). Data on the association between TRA and AKI in this setting of STEMI are limited and with conflicting results.
Methods
UNASSIGNED
We systematically searched PubMed, Embase, and Scopus for abstracts and full-text articles from inception to July 13
Results
UNASSIGNED
A total of 10,093 studies were found. After applying our inclusion criteria, 5 studies from 2014 to 2021 with a total of 8,536 STEMI patients were included. TRA was not significantly associated with a reduced risk for AKI compared with TFA (odds ratio 0.85, 95% CI 0.71-1.01,
Conclusions
UNASSIGNED
Transradial access was not significantly associated with lower risk of AKI in patients undergoing primary PCI for STEMI compared with TFA. Larger studies are needed to clarify this outcome.
Identifiants
pubmed: 35360090
doi: 10.1155/2022/6774439
pmc: PMC8930211
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6774439Informations de copyright
Copyright © 2022 Gaspar Del Rio-Pertuz et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
J Am Coll Cardiol. 2003 Jul 16;42(2):211-6
pubmed: 12875753
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E518-E526
pubmed: 30244540
Am Heart J. 2005 Aug;150(2):330-7
pubmed: 16086939
JAMA. 2010 Jun 2;303(21):2156-64
pubmed: 20516416
Circ Cardiovasc Interv. 2021 Mar;14(3):e009994
pubmed: 33685220
Heart. 2015 Nov;101(22):1778-85
pubmed: 26243789
J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9
pubmed: 22858390
J Am Coll Cardiol. 2014 Mar 18;63(10):964-72
pubmed: 24211309
Cardiovasc Revasc Med. 2016 Dec;17(8):546-551
pubmed: 27566903
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
Lancet. 2018 Sep 8;392(10150):835-848
pubmed: 30153988
Cardiology. 2021;146(6):678-689
pubmed: 34348269
J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9
pubmed: 15464318
Circ Cardiovasc Interv. 2014 Apr;7(2):190-8
pubmed: 24569598
J Am Coll Cardiol. 2020 Sep 1;76(9):1084-1101
pubmed: 32854844
J Am Coll Cardiol. 2017 May 11;:
pubmed: 28528767
Am J Cardiol. 2021 Sep 15;155:16-22
pubmed: 34284868
Am J Cardiol. 2014 Sep 15;114(6):820-5
pubmed: 25073568
Circ Cardiovasc Interv. 2016 Sep;9(9):
pubmed: 27582110
Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):333-8
pubmed: 27050627
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Am Coll Cardiol. 2012 Dec 18;60(24):2490-9
pubmed: 23103036
Can J Cardiol. 2016 Jun;32(6):777-90
pubmed: 27233893
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Exp Ther Med. 2020 Nov;20(5):42
pubmed: 32952633
Am Heart J. 2021 Apr;234:12-22
pubmed: 33422518